Caption Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 917 |
|
|
2024
Q3 | – | Sell |
-6,000
| Closed | -$91.4K | – | 792 |
|
|
2024
Q2 | $91.4K | Buy |
6,000
+1,000
| +20% | +$15.2K | ﹤0.01% | 324 |
|
|
2024
Q1 | $94.4K | Sell |
5,000
-14,900
| -75% | -$281K | ﹤0.01% | 311 |
|
|
2023
Q4 | $380K | Buy |
19,900
+11,900
| +149% | +$227K | 0.01% | 247 |
|
|
2023
Q3 | $144K | Buy |
+8,000
| New | +$144K | ﹤0.01% | 320 |
|
|
2023
Q2 | – | Sell |
-9,000
| Closed | -$164K | – | 690 |
|
|
2023
Q1 | $164K | Buy |
+9,000
| New | +$164K | ﹤0.01% | 253 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 780 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 820 |
|
|
2022
Q2 | – | Sell |
-21,740
| Closed | -$686K | – | 838 |
|
|
2022
Q1 | $686K | Buy |
+21,740
| New | +$686K | 0.01% | 292 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 584 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 563 |
|